Skip to content

Clinical trials

Completed Phase 3 Tuberculosis, Multidrug-Resistant trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Tuberculosis, Multidrug-Resistant Phase: Phase 3 Status: Completed Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20131
20141
20152
20162
20171
20191
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Global Alliance for TB Drug Development3
Médecins Sans Frontières, France2
IUATLD, Inc1
Immunitor LLC1
Lisichansk Regional Tuberculosis Dispensary1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Scientific Center for Anti-infectious Drugs, Kazakhstan1
Wits Health Consortium (Pty) Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Tuberculosis, Multidrug-Resistant11
Tuberculosis9
Extensively Drug-Resistant Tuberculosis5
Tuberculosis, Pulmonary4
Bacterial Infections2
Gram-Positive Bacterial Infections1
Mycobacterium Infections1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.